FPIN's Clinical Inquiries

Gabapentin for Treatment of Radicular Low Back Pain

 

Am Fam Physician. 2019 Sep 1;100(5):309-310.

Clinical Question

Is gabapentin (Neurontin) effective for the treatment of radicular low back pain?

Evidence-Based Answer

Gabapentin is not effective for the treatment of radicular low back pain and is associated with adverse effects. (Strength of Recommendation: B, based on a systematic review of low-quality randomized controlled trials [RCTs].)

Evidence Summary

A 2017 systematic review and meta-analysis of eight RCTs (N = 874) examined the effectiveness of gabapentin or pregabalin (Lyrica) vs. placebo for the treatment of chronic low back pain.1 This review searched Medline, EMBASE, and the Cochrane database from inception until December 2016 and included RCTs evaluating the use of gabapentin or pregabalin for more than three months in adults with chronic low back pain with or without leg pain. The review identified three RCTs (n = 185) that specifically examined gabapentin. Compared with the control group, patients who received gabapentin had no significant difference in chronic low back pain (mean difference = −0.22 points on a 0- to 10-point scale; 95% CI, −0.51 to 0.07), with a GRADE rating of very low-quality evidence. There was also no difference in pain relief between groups (two trials; n = 120; risk ratio [RR] = 0.96; 95% CI, 0.061 to 1.49). Compared with placebo, gabapentin had more adverse effects, including dizziness (three trials; n = 121; RR = 2.0; 95% CI, 1.2 to 3.4; number needed to harm [NNH] = 7), fatigue (three trials; n = 121; RR = 1.9; 95% CI, 1.1 to 3.0; NNH = 8), difficulties with mentation (three trials; n = 121; RR = 3.3; 95% CI, 1.5 to 7.3; NNH = 6); and visual disturbances (three trials; n = 121; RR = 5.7; 95% CI, 1.9 to 17; NNH = 6).

A 2016 double-blind RCT (N = 108) investigated gabapentin as a treatment for chronic low back pain with and without a radicular component.2 This RCT was included in the 2017 meta-analysis but is reviewed here separately because it was the largest trial and reviewed multiple additional outcomes not included in the systematic review. P

Address correspondence to Corey Lyon, DO, at corey.lyon@ucdenver.edu. Reprints are not available from the authors.

Author disclosure: No relevant financial affiliations.

References

1. Shanthanna H, Gilron I, Rajarathinam M, et al. Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017;14(8):e1002369.

2. Atkinson JH, Slater MA, Capparelli EV, et al. A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain. 2016;157(7):1499–1507.

3. Chou R, Deyo R, Friedly J, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med. 2017;166(7):480–492.

Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email: questions@fpin.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, Associate Medical Editor.

A collection of FPIN's Clinical Inquiries published in AFP is available at https://www.aafp.org/afp/fpin.

 

 

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Nov 1, 2019

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article